Development of an H9N2 vaccine strain with enhanced neuraminidase immunogenicity via dual hemagglutinin and neuraminidase modification. [PDF]
Song JH +7 more
europepmc +1 more source
Cross-reactive H5N1 Neuraminidase Antibodies by Age and Influenza A Imprinting Cohorts of the Past Century: Population-Based Serosurvey, British Columbia, Canada. [PDF]
Skowronski DM +12 more
europepmc +1 more source
Isolation, identification, and whole genome sequencing analysis of influenza A virus clinical isolates from Shanghai, China, during 2022-2023. [PDF]
Raza MA +13 more
europepmc +1 more source
Understanding H3N2 subclade K: a public health concern for the 2026 influenza season. [PDF]
Haq MAU, Ahmed Z, Khan MA, Fatima M.
europepmc +1 more source
Discovery of Influenza Neuraminidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation of Novel Chemotypes. [PDF]
Gitto R +6 more
europepmc +1 more source
Molecular Epidemiology and Genetic Diversity of Influenza B Viruses Based on Whole-Genome Analysis in Japan and Myanmar, 2016-2020. [PDF]
Ichikawa Y +16 more
europepmc +1 more source
Anti-neuraminidase and anti-HA stalk antibodies reduce the susceptibility to and infectivity of influenza A/H3N2 virus. [PDF]
Hoy G +13 more
europepmc +1 more source
Examining the Threat of H5N1 Highly Pathogenic Avian Influenza to Human Health. [PDF]
Blais-Savoie J +10 more
europepmc +1 more source
Hemagglutinin-displaying influenza nanovaccines: progress and promise. [PDF]
Kim D +5 more
europepmc +1 more source
Molecular characterization and phylogeography of equine influenza virus H3N8 detected in donkeys in Nigeria 2022-2023. [PDF]
Mkpuma N +7 more
europepmc +1 more source

